-+ 0.00%
-+ 0.00%
-+ 0.00%

AMYLYX PHARMACEUTICALS INC - AVEXITIDE PHASE 3 LUCIDITY TRIAL TOPLINE DATA READOUT ANTICIPATED IN Q3 2026

Reuters·05/05/2026 11:03:30

Please log in to view news